Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis.

CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. Abstract Text:

    hee sun parkHee Sun Park,jeong min leeJeong Min Lee,se hyung kimSe Hyung Kim,jun yong jeongJun Yong Jeong,young jun kimYoung Jun Kim,kyoung ho leeKyoung Ho Lee,seung hong choiSeung Hong Choi,joon koo hanJoon Koo Han,byung ihn choiByung Ihn Choi,

    OBJECTIVE: The objective of our study was to determine useful CT findings for differentiating cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. MATERIALS AND METHODS: CT images of 30 patients with hepatolithiasis and pathologically proven cholangiocarcinoma (n = 14) or periductal fibrosis (n = 16) were retrospectively reviewed. Helical CT scans were obtained before, 30 seconds after, and 65 seconds after the start of contrast material injection. Analysis of CT findings included evaluation for the presence of periductal soft-tissue density, bile duct wall thickening at the stricture site, ascites, portal vein obliteration, lymph node enlargement, and a duct stone; assessment of the degree of ductal dilatation; and evaluation of the enhancement pattern of periductal lesions, thickened ductal wall, and hepatic parenchyma. The CT attenuation coefficients of the thickened ductal wall and adjacent normal-looking bile duct were measured on images obtained during each phase. Among these findings, statistically significant variables were determined using the Fisher's exact test and Student's t test. Sensitivity and specificity values of the CT criteria were also calculated. RESULTS: The presence of periductal soft-tissue density (p = 0.002), higher enhancement of the duct than adjacent bile duct on portal venous phase images (p = 0.008), ductal wall thickening (p = 0.026), portal vein obliteration (p = 0.031), and lymph node enlargement (p = 0.031) were found to be the significant findings for differentiating cholangiocarcinoma from fibrosis in patients with hepatolithiasis. When any two or more of these five criteria were used in combination, we could identify 100% of the patients with cholangiocarcinoma but only 12.5% of the patients with fibrosis. CONCLUSION: Cholangiocarcinoma in patients with hepatolithiasis can be diagnosed using specific CT criteria.

    CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. Publishing Authors By Initials

    hs parkHS Park,jm leeJM Lee,sh kimSH Kim,jy jeongJY Jeong,yj kimYJ Kim,kh leeKH Lee,sh choiSH Choi,jk hanJK Han,bi choiBI Choi,

    For similar tomography, x-ray computed research abstracts see: tomography, x-ray computed research

    PUBMED ID PMID:

    MEDLINE DATE:

    CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: AJR. American journal of roentgenology

    VOLUME: 187

    Page Numbers: 445-53

    Journal Abbreviation:

    ISSN: 1546-3141

    DAY: 15

    MONTH: Aug

    YEAR: 2006

    CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7708173

    CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. Keywords Mesh Terms:

    KEYWORDS: Tomography, X-Ray Computed

    MESH TERMS: complications

    Chemical & Substance for Abstract: CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis.

    AFFILIATION: Department of Radiology and Institute of Radiation Medicine, Seoul National University College of Medicine, 28, Yongon-dong, Chongno-gu, Seoul 110-744, Korea.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: AJR Am J Roentgenol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News